Mobile Menu

Pharmaceuticals Packing & Labeling Services in the US - Market Research Report (2015-2030)

Marley Brocker Marley Brocker New York, United States Last Updated: November 2025 NAICS OD5678

Revenue

$758.4m

2025

$758.4m

Past 5-Year Growth

Profit

$XXX.Xm

Employees

3,155

Businesses

104

Wages

$XXX.Xm

Pharmaceuticals Packing & Labeling Services in the US industry analysis

Demographic and economic factors that have fueled healthcare spending have led to rising sales of prescription and over-the-counter (OTC) pharmaceuticals. At the same time, cost and operational pressures affecting drugmakers have prompted them to seek partnerships and contract services, including packaging and labeling. These factors have driven growth for pharmaceutical packaging and labeling providers, expanding their role in domestic pharmaceutical production. The pharmaceutical industry's dependence on contract packaging and labeling providers has also been driven by a wave of patent losses affecting brand-name prescription drugs and increasingly complex drug development processes, particularly in resource-intensive areas such as cell therapy, rare diseases, and personalized medicine. In total, revenue is expected to expand at a CAGR of 10.2% to an estimated $959.2 million by 2025, with a projected 3.5% increase in 2025.

In addition to the sharp rise in spending that fueled double-digit revenue growth for packaging and labeling providers from 2020 to 2022, the pandemic's disruption to the pharmaceutical supply chain has pressured drugmakers to develop more resilient ones. While this requires a multifaceted approach, movements toward onshoring production and outsourcing have already begun to benefit pharmaceutical packaging providers with more opportunities to support domestic drug production. Federal investment directed toward strengthening domestic drug production has helped catalyze these changes, with the Biden administration leveraging its authorities under the Defense Production Act and the second Trump administration ramping up the push for domestic drug manufacturing through an Executive Order.

Rapidly evolving trends in the broader pharmaceutical market will help contract packaging and labeling providers gain a more central role in drug production moving forward. Biotechnology producers facing lengthy and expensive development processes will depend on outsourcing the most. While the momentum toward onshoring will be a major opportunity, advances in technology, sustainability measures, regulatory requirements and an aging population will also strengthen the industry. With overall drug spending set to surpass $1.0 trillion for the first time in 2030, industry revenue is projected to grow at a CAGR of 3.3% to an estimated $1.1 billion over the next five years.

Trends and Insights

  • Outsourcing of pharmaceutical packaging and labeling is integral to advancing biologics development. Newer and smaller companies specializing in biologics increasingly depend on outsourcing, including packaging and labeling, to access the complex processes they need but lack the capacity to support in-house.
  • Tariffs on APIs and packaging materials from key suppliers like China, India and Canada could delay manufacturing and strain global supply chains. This disruption could worsen preexisting shortages of essential medications, especially generics, as companies struggle to adapt to higher costs and sourcing challenges.
  • Regions with active life science ecosystems strengthen pharmaceutical packing providers. Packaging and labeling companies in the Mid-Atlantic and Western US benefit from the region’s access to pharmaceutical giants, innovative start-ups and highly skilled workforces.
  • Pharmaceutical packaging providers need to sway manufacturers away from in-house processes. Smaller companies lacking the capital or infrastructure to develop in-house capabilities are easier targets, but larger manufacturers have expansive resources, access to capital and established systems in place.
Show more

Get more expert insights that help you cut through the noise.

Get fast answers to complex questions about your business or your client’s industry. Annual memberships include unlimited access to data and analysis for thousands of industries globally.

Get in Touch

Unlock Expert Insights with Full Platform Access

  • Human Driven & Verified Analysis
  • Structured Database Powering Workflows
  • Intelligent Tools Empowering Confident Decisions
  • Insight where-and how- you need them

How you can access insights on the Pharmaceuticals Packing & Labeling Services in the US industry

The Pharmaceuticals Packing & Labeling Services in the US Industry Report is available in multiple formats to fit seamlessly into your workflow.

IBISWorld Platform

Answer any industry question in minutes with our entire database at your fingertips.

Screen of the IBISWorld platform user interface Book a demo

API Data Delivery

Feed trusted, human-driven industry intelligence straight into your platform.

Code example of using the IBISWorld API API documentation

Integrations

Streamline your workflow with IBISWorld’s intelligence built into your toolkit.

Screen of Client Application integrating with IBISWorld data View integrations

Related Coverage

Understand the landscape with full access to an IBISWorld license

Competitors

  • There are no industries to display.

Industry Statistics and Trends

Market size and recent performance (2015-2030)

Industry revenue has grown at a CAGR of 5.2 % over the past five years, to reach an estimated $758.4m in 2025.

Trends and Insights

Pharmaceutical producers look toward outsourcing as a cost-effective solution

  • Several strong tailwinds are driving the rise in pharmaceutical utilization in the US. A growing number of adults 65 and older, increasing rates of chronic illnesses and comorbidities and longer life expectancies are all contributing to higher pharmaceutical demand. For example, data from the National Council on Aging shows that 72.0% of US adults have at least one chronic condition, costing the healthcare system over $1.0 trillion annually, including pharmaceuticals.
  • Additional trends and insights available with purchase
Pharmaceuticals Packing & Labeling Services in the US
Revenue (2015-2030)
IBISWorld Logo Source: IBISWorld

Industry outlook (2025-2030)

Market size is projected to grow over the next five years.

Trends and Insights

Prescription drug spending set to rise as specialty drugs come onto the market

  • Pharmaceutical spending is projected to continue rising from 2025 to 2030, with retail prescription drug expenditures expected to grow at an average annual rate of 5.2%, according to the Centers for Medicare and Medicaid Services (CMS). By 2030, overall drug spending will surpass $1.0 trillion for the first time, driven by increased utilization, new drug launches and sustained demand for innovative therapies.​

Biggest companies in the Pharmaceuticals Packing & Labeling Services in the US

Company
Market Share (%)
2025
Revenue
2025
Profit
2025
Profit Margin (%)
2025

There are no companies that hold a market share exceeding 5% in the Pharmaceuticals Packing & Labeling Services in the US industry.

Products & Services Segmentation

Pharmaceuticals Packing & Labeling Services in the US
Products & Services
IBISWorld Logo Source: IBISWorld

Industry revenue is measured across several distinct product and services lines, including Packaging services, Labeling services and Other services. Packaging services is the largest segment of the Pharmaceuticals Packing & Labeling Services in the US.

Trends and Insights

Packaging services shift as pharma adapts to new safety and speed standards

  • Packaging services encompass a range of processes that protect pharmaceutical drugs from damage and contamination, while ensuring a clear presentation for end-users. This segment encompasses bagging, wrapping, bundling, cartoning, case packing, filling and repacking using various formats, including shrink banding, clamshells and blister packs. Most packaging systems in the US include primary, secondary and tertiary stages to protect, group and transport medicines.
  • More insights available in the full report

Table of Contents

About this industry

Industry definition

Pharmaceutical packaging and labeling companies specialize in preparing medications and healthcare products for distribution by designing and providing appropriate packaging and labeling solutions.

What's included in this industry?

Products and services covered in the Pharmaceuticals Packing & Labeling Services industry in the United States include Packaging services, Labeling services and Other services.

Companies

Companies covered in the Pharmaceuticals Packing & Labeling Services industry in the United States include .

Purchase this report to view all major companies in this industry.

Related Terms

Related terms covered in the Pharmaceuticals Packing & Labeling Services industry in the United States include biologic, outsource, ampoules, small-molecule drug, injectables and drug delivery system.

Industry Code

NAICS 2017

NAICS 561910 - Pharmaceuticals Packing & Labeling Services in the US

Performance

Get an indication of the industry's health through historical, current and forward-looking trends in the performance indicators that make or break businesses.

Analyst insights

Outsourcing of pharmaceutical packaging and labeling is integral to advancing biologics development. Newer and smaller companies specializing in biologics increasingly depend...

In this chapter (4)

  • Current Performance
  • Outlook
  • Volatility
  • Life Cycle

Key metrics

  • Annual Revenue, Recent Growth, Forecast, Revenue Volatility
  • Number of Employees, Recent Growth, Forecast, Employees per Business, Revenue per Employee
  • Number of Businesses, Recent Growth, Forecast, Employees per Business, Revenue per Business
  • Total Profit, Profit Margin, Profit per Business

Charts

  • Revenue, including historical (2015-2024) and forecast (2025-2030)
  • Employees, including historical (2015-2024) and forecast (2025-2030)
  • Businesses, including historical (2015-2024) and forecast (2025-2030)
  • Profit, including historical (2015-2025)
  • Industry Volatility vs. Revenue Growth
  • Industry Life Cycle

Detailed analysis

  • Trends in supply, demand and current events that are driving current industry performance
  • Expected trends, economic factors and ongoing events that drive the industry's outlook
  • Key success factors for businesses to overcome volatility
  • How contribution to GDP, industry saturation, innovation, consolidation, and technology and systems influence the industry's life cycle phase.

Products and Markets

Learn about an industry's products and services, markets and trends in international trade.

Analyst insight

Tariffs on APIs and packaging materials from key suppliers like China, India and Canada could delay manufacturing and strain global supply chains. This disruption could worse...

In this chapter

  • Products & Services
  • Major Markets

Key metrics

  • Largest market segment and value in 2025
  • Product innovation level

Charts

  • Products & services segmentation in 2025
  • Major market segmentation in 2025

Detailed analysis

  • Trends impacting the recent performance of the industry's various segments
  • Innovations in the industry's product or service offering, specialization or delivery method
  • Key factors that successful businesses consider in their offerings
  • Buying segments and key trends influencing demand for industry products and services

Geographic Breakdown

Discover where business activity is most concentrated in an industry and the factors driving these trends to find opportunities and conduct regional benchmarking.

Analyst insights

Regions with active life science ecosystems strengthen pharmaceutical packing providers. Packaging and labeling companies in the Mid-Atlantic and Western US benefit from the ...

In this chapter (1)

  • Business Locations

Charts

  • Share of revenue, establishment, wages and employment in each state
  • Share of population compared to establishments in each region in 2025

Tables

  • Number and share of establishments in each state in 2025
  • Number and share of revenue each state accounts for in 2025
  • Number and share of wages each state accounts for in 2025
  • Number and share of employees in each state in 2025

Detailed analysis

  • Geographic spread of the industry across North America, and trends associated with changes in the business landscape
  • Key success factors for businesses to use location to their advantage

Competitive Forces

Get data and insights on what's driving competition in an industry and the challenges industry operators and new entrants may face, with analysis built around Porter's Five Forces framework.

Analyst insights

Pharmaceutical packaging providers need to sway manufacturers away from in-house processes. Smaller companies lacking the capital or infrastructure to develop in-house capabi...

In this chapter (4)

  • Concentration
  • Barriers to Entry
  • Substitutes
  • Buyer & Supplier Analysis

Key metrics

  • Industry concentration level
  • Industry competition level and trend
  • Barriers to entry level and trend
  • Substitutes level and trend
  • Buyer power level and trend
  • Supplier power level and trend

Charts

  • Market share concentration among the top 4 suppliers from 2020-2025
  • Supply chain including upstream supplying industries and downstream buying industries, flow chart

Detailed analysis

  • Factors impacting the industry’s level of concentration, such as business distribution, new entrants, or merger and acquisition activity.
  • Key success factors for businesses to manage the competitive environment of the industry.
  • Challenges that potential industry entrants face such as legal, start-up costs, differentiation, labor/capital intensity and capital expenses.
  • Key success factors for potential entrants to overcome barriers to entry.
  • Competitive threats from potential substitutes for the industry’s own products and services.
  • Key success factors for how successful businesses can compete with substitutes.
  • Advantages that buyers have to keep favorable purchasing conditions.
  • Advantages that suppliers have to maintain favorable selling conditions.
  • Key success factors for how businesses can navigate buyer and supplier power.

Companies

There are no companies that hold a market share exceeding 5% in the Pharmaceuticals Packing & Labeling Services in the US industry.

Analyst insights

An expanding market keeps concentration low. This dynamic allows pharmaceutical packaging and labeling providers to differentiate themselves through specialized services and ...

External Environment

Understand the demographic, economic and regulatory factors that shape how businesses in an industry perform.   

Analyst insights

Rising drug utilization from a growing number of adults 65 and older boosts drug production. Pharmaceutical producers will send more packaging and labeling needs to the indus...

In this chapter

  • External Drivers
  • Regulation & Policy
  • Assistance

Key metrics

  • Regulation & policy level and trend
  • Assistance level and trend

Charts

  • Regulation & Policy historical data and forecast (2015-2030) 
  • Assistance historical data and forecast (2015-2030) 

Detailed analysis

  • Demographic and macroeconomic factors influencing the industry, including Regulation & Policy and Assistance
  • Major types of regulations, regulatory bodies, industry standards or specific regulations impacting requirements for industry operators
  • Key governmental and non-governmental groups or policies that may provide some relief for industry operators.

Financial Benchmarks

View average costs for industry operators and compare financial data against an industry's financial benchmarks over time. 

Analyst insights

Purchase this report to unlock analyst insights.

In this chapter

  • Cost Structure
  • Financial Ratios
  • Key Ratios

Key metrics

  • Profit margin, and how it compares to the sector-wide margin
  • Average wages, and how it compares to the sector-wide average wage
  • Largest cost component as a percentage of revenue
  • Industry average ratios for days' receivables, industry coverage and debt-to-net-worth ratio

Charts

  • Average industry operating costs as a share of revenue, including purchases, wages, depreciation, utilities, rent, other costs and profit in 2025
  • Average sector operating costs as a share of revenue, including purchases, wages, depreciation, utilities, rent, other costs and profit in 2025
  • Investment vs. share of economy

Data tables

  • Industry Multiples (2018-2023)
  • Industry Tax Structure (2018-2023)
  • Income Statement (2018-2023)
  • Balance Sheet (2018-2023)
  • Liquidity Ratios (2018-2023)
  • Coverage Ratios (2018-2023)
  • Leverage Ratios  (2018-2023)
  • Operating Ratios (2018-2023)
  • Cash Flow & Debt Service Ratios (2015-2030)
  • Revenue per Employee (2015-2030)
  • Revenue per Enterprise (2015-2030)
  • Employees per Establishment (2015-2030)
  • Employees per Enterprise (2015-2030)
  • Average Wage (2015-2030)
  • Wages/Revenue (2015-2030)
  • Establishments per Enterprise (2015-2030)
  • IVA/Revenue (2015-2030)
  • Imports/Demand (2015-2030)
  • Exports/Revenue (2015-2030)

Detailed analysis

  • Trends in the cost component for industry operators and their impact on industry costs and profitability 

Key Statistics

Industry Data

Data Tables

Including values and annual change:

  • Revenue (2015-2030)
  • IVA (2015-2030)
  • Establishments (2015-2030)
  • Enterprises (2015-2030)
  • Employment (2015-2030)
  • Exports (2015-2030)
  • Imports (2015-2030)
  • Wages (2015-2030)

Top Questions Answered

Unlock comprehensive answers and precise data upon purchase. View purchase options.

What is the market size of the Pharmaceuticals Packing & Labeling Services industry in the United States in 2025?

The market size of the Pharmaceuticals Packing & Labeling Services industry in the United States is $758.4m in 2025.

How many businesses are there in the Pharmaceuticals Packing & Labeling Services industry in the United States in 2025?

There are 104 businesses in the Pharmaceuticals Packing & Labeling Services industry in the United States, which has grown at a CAGR of 5.4 % between 2020 and 2025.

How may import tariffs affect the Pharmaceuticals Packing & Labeling Services industry in the United States?

The Pharmaceuticals Packing & Labeling Services industry in the United States is unlikely to be materially impacted by import tariffs with imports accounting for a low share of industry revenue.

How may export tariffs affect the Pharmaceuticals Packing & Labeling Services industry in the United States?

The Pharmaceuticals Packing & Labeling Services industry in the United States is unlikely to be materially impacted by export tariffs with exports accounting for a low share of industry revenue.

Has the Pharmaceuticals Packing & Labeling Services industry in the United States grown or declined over the past 5 years?

The market size of the Pharmaceuticals Packing & Labeling Services industry in the United States has been growing at a CAGR of 5.2 % between 2020 and 2025.

What is the forecast growth of the Pharmaceuticals Packing & Labeling Services industry in the United States over the next 5 years?

Over the next five years, the Pharmaceuticals Packing & Labeling Services industry in the United States is expected to grow.

What does the Pharmaceuticals Packing & Labeling Services industry in the United States include?

Packaging services and Labeling services are part of the Pharmaceuticals Packing & Labeling Services industry in the United States.

How competitive is the Pharmaceuticals Packing & Labeling Services industry in the United States?

The level of competition is moderate and steady in the Pharmaceuticals Packing & Labeling Services industry in the United States.

Methodology

How are IBISWorld reports created?

IBISWorld has been a leading provider of trusted industry research for over 50 years to the most successful companies worldwide. With offices in Australia, the United States, the United Kingdom, Germany and China, we are proud to have local teams of analysts that conduct research, data analysis and forecasting to produce data-driven industry reports.

Our analysts start with official, verified and publicly available sources of data to build the most accurate picture of each industry. Analysts then leverage their expertise and knowledge of the local markets to synthesize trends into digestible content for IBISWorld readers. Finally, each report is reviewed by one of IBISWorld’s editors, who provide quality assurance to ensure accuracy and readability.

IBISWorld relies on human-verified data and human-written analysis to compile each standard industry report. We do not use generative AI tools to write insights, although members can choose to leverage AI-based tools within the platform to generate additional analysis formats.

What data sources do IBISWorld analysts use?

Each industry report incorporates data and research from government databases, industry-specific sources, industry contacts, and our own proprietary database of statistics and analysis to provide balanced, independent and accurate insights.

Key data sources in the US include: 

  • US Census Bureau
  • US Bureau of Labor Statistics
  • US International Trade Commission

Analysts also use industry specific sources to complement catch-all sources, although their perspective may focus on a particular organization or representative body, rather than a clear overview of all industry operations. However, when balanced against other perspectives, industry-specific sources provide insights into industry trends.

These sources include:

  • Industry and trade associations
  • Industry federations or regulators
  • Major industry players annual or quarterly filings

Finally, IBISWorld’s global data scientists maintain a proprietary database of macroeconomic and demand drivers, which our analysts use to help inform industry data and trends. They also maintain a database of statistics and analysis on thousands of industries, which has been built over our more than 50-year history and offers comprehensive insights into long-term trends.

How does IBISWorld forecast its data?

IBISWorld’s analysts and data scientists use the sources above to create forecasts for our proprietary datasets and industry statistics. Depending on the dataset, they may use regression analysis, multivariate analysis, time-series analysis or exponential smoothing techniques to project future data for the industry or driver. Additionally, analysts will leverage their local knowledge of industry operating and regulatory conditions to impart their best judgment on the forecast model.

IBISWorld prides itself on being a trusted, independent source of data, with over 50 years of experience building and maintaining rich datasets and forecasting tools. We are proud to be the keystone source of industry information for thousands of companies across the world.

Learn more about our methodology and data sourcing on the Help Center.

feedback